sb 203580 has been researched along with cucurbitacin i in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (cucurbitacin i) | Trials (cucurbitacin i) | Recent Studies (post-2010) (cucurbitacin i) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 108 | 2 | 70 |
| Protein | Taxonomy | sb 203580 (IC50) | cucurbitacin i (IC50) |
|---|---|---|---|
| Integrin alpha-L | Homo sapiens (human) | 0.95 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Jiang, W; Li, H; Li, R; Liu, Z; Wang, X; Wu, S; Wu, Y; Xin, J; Zhu, L | 1 |
1 other study(ies) available for sb 203580 and cucurbitacin i
| Article | Year |
|---|---|
Cucurbitacin-I induces hypertrophy in H9c2 cardiomyoblasts through activation of autophagy via MEK/ERK1/2 signaling pathway.
Topics: Atrial Natriuretic Factor; Autophagy; Cardiomegaly; Cell Size; Cell Survival; Humans; Imidazoles; MAP Kinase Kinase 4; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Myoblasts, Cardiac; Natriuretic Peptide, Brain; Protein Kinase Inhibitors; Pyridines; Signal Transduction; Triterpenes | 2016 |